Atorvastatin clinical trials cholesterol lowering intervention

Lipitor

Recap Results Trial description old Pinterest treatment           Z

Acute coronary syndrome

4 trials  - ESTABLISH - PROVE IT - TIMI 22 - Colivicchi - MIRACL

Acute myocardial infarction

1 trials  - PROVE-IT

Aortic stenosis

1 trials  - SALTIRE

Atrial fibrillation

Patient with history of atrial fibrillation:  5 trials  - Almroth - Dernellis - Ozaydin - MIRACL (sub-group) (Schwartz) - STOP-AF

Patients without history of AF (primary prevention):  3 trials  - ARMYDA-3 (AF ancillary study) - Chello - MIRACL (AF ancillary study)

CABG surgery

2 trials  - Chello et al. - Patti et al.

Cardiovascular prevention

All chronical situations:  15 trials  - SAGE - ASPEN - SPARCL - Deutsche Diabetes Dialyse Studie (4D) - IDEAL - Strey - TNT - Vascular basis - CARDS - PROVE-IT - REVERSAL - ASCOT - Mohler III - GREACE - AVERT

Diabetic patients :  6 trials  - ASPEN - ASPEN - TNT (diabetic sub group) - Deutsche Diabetes Dialyse Studie (4D) - CARDS - ASCOT (diabetics sub group)

High risk patients with or without LDL cholesterol elevation:  1 trials  - ASCOT

Hypertensive patients:  1 trials  - ASCOT

Patient with related disease:  1 trials  - SALTIRE

Patients with prior MI or with CHD:  12 trials  - SAGE - IDEAL - macin - TNT - Vascular basis - ESTABLISH - PROVE IT - TIMI 22 - PROVE-IT - REVERSAL - Colivicchi - GREACE - MIRACL

Patients with renal insufficiency (on hemodialysis or transplant):  1 trials  - Deutsche Diabetes Dialyse Studie (4D)

Post stroke (or TIA) :  1 trials  - SPARCL

Primary prevention:  4 trials  - ASPEN (primary prevention sub group) - CARDS - ASCOT - Mohler

Secondary prevention:  8 trials  - SAGE - IDEAL - TNT - Vascular basis - REVERSAL - Mohler - GREACE - AVERT

Women:  1 trials  - ASCOT (women subgroup)

Diabetes type 2

Diabetic patients with or withour hypercholesterolemia:  4 trials  - ASPEN - TNT (diabetic sub group) - CARDS - ASCOT (diabetics sub group)

Primary prevention:  3 trials  - ASPEN (primary prevention sub group) - CARDS - ASCOT (diabetics sub group)

Secondary prevention:  1 trials  - TNT (diabetic sub group)

Heart failure

All type of patients:  4 trials  - Yamada - Sola - Wojnicz - Strey

Hypertension

1 trials  - ASCOT

Percutaneous coronary intervention

5 trials  - ARMYDA-RECAPTURE - NAPLES II (Briguori) - ARMYDA - GAIN - ESTATE

Peripheral vascular diseases

1 trials  - Mohler III

Post myocardial infarction

5 trials  - SAGE - IDEAL - TNT - Vascular basis - REVERSAL

Post stroke

1 trials  - SPARCL